Structural redesign of selected non-steroidal estrogen receptor binding compounds has previously been successful in the discovery of new inhibitors of tubulin assembly. Accordingly, tetra-substituted alkene analogues (21–30) were designed based in part on combinations of the structural and electronic components of tamoxifen and combretastatin A- 4 (CA4). The McMurry coupling reaction was used as the key synthetic step in the ...